Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 70181Generated: October 29, 2026

Morpholine → Tert-butyl 4-(2-morpholinooxazole-4-carbonyl)-3-((pyridin-3-yloxy)methyl)piperazine-1-carboxylate

https://huagongshe.com/reaction/70181

Reaction equation

Participants

RoleNameHCIDCharge
ReactantMorpholineHCID 8083—
ReactantPotassium CarbonateHCID 11430—
ReactantTert-butyl 4-(2-chlorooxazole-4-carbonyl)-3-((pyridin-3-yloxy)methyl)piperazine-1-carboxylateHCID 59671603—
SolventTetrahydrofuranHCID 8028—
ProductTert-butyl 4-(2-morpholinooxazole-4-carbonyl)-3-((pyridin-3-yloxy)methyl)piperazine-1-carboxylateHCID 59671482125.8%

Reaction Steps

A solution of tert-butyl 4-(2-chlorooxazole-4-carbonyl)-3-((pyridin-3-yloxy)methyl)piperazine-1-carboxylate (117 mg, 0.277 mmol), morpholine (48 mg, 0.554 mmol) and potassium carbonate (76 mg, 0.554 mmol) in THF (2 mL) was heated to 70° C. overnight. Upon cooling to rt, the reaction mixture was filtered and concentrated under reduced pressure. The material was purified by HPLC (5 to 50% MeCN/0.1% TFA in H2O/0.1% TFA gradient), yielding 165 mg (100%) of the title compound as the TFA salt. LC-MS: RT=6.60 min, [M+H]+=474.1.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08822472B2
Source datasetuspto-grants-2014_09
ORD IDord-c491fec13fb04f98bf3b436a82cf542c
Source noteuspto-grants-2014_09